The American Medical Association is like a union for doctors. The AMA is typically given the kind of respect that the public gives to doctors, but it is a lobbying organization that has always
profited from selling its influence. Its entire history, the AMA has behaved more like a greedy, for-profit corporation than like a public-interest group and it has promoted drugs and even tobacco in exchange for corporate cash.
[T]he AMA eventually decided to sell advertising space for its medical
journal JAMA to drug companies. Expanding on this business model, AMA
President George Simmons decided to create the “AMA seal-of-approval”
for favored drugs in 1899, resulting in a five-fold increase in
advertising revenue by 1909. Simmons, it turned out, had no credible
medical credentials and the AMA did no drug testing for the products
given the seal-of-approval.
...Simmons’
focus on molding public opinion also became one of the greatest weapons
of the AMA – his “Propaganda Department”
would soon expand to communicate the AMA’s views through a column
syndicated published in over 200 newspapers, a weekly radio program, and
various books about how homeopathic practices and non-AMA approved
drugs were “quackery.”
Through the 1930s to 1950s ...the tobacco industry leaned on the AMA to substantiate its
dubious health claims. Beginning in 1933, JAMA published tobacco
advertisements, stating that it had done so only “after careful
consideration of the extent to which cigarettes were used by physicians in practice.”
The tobacco industry became the AMA’s largest advertiser, and its
implicit endorsement of tobacco products allowed companies like Camel to
proclaim slogans such as, “More doctors smoke Camels than any other
cigarette.”
...[Today the] AMA derives at least a fifth of its budget from drug companies through an arrangement known as “licensure.”
The program consists of AMA selling drug companies its “Masterfile” of
doctor profiles, spanning everything from detailed biographic
information to an individual doctor’s prescription-writing history. The
program is extremely controversial since drug companies in turn use the
information to aggressively market their products to doctors.
Controversial drugs Vioxx and Avandia, which have
subsequently been found to pose significant risks to patients, have been
marketed to doctors, in some cases, using information obtained from the
AMA.
After an uproar in 2007, the AMA, through a policy of
self-regulation, claimed to have stopped selling doctor
prescription-writing information. But that pledge must be viewed with skepticism given the AMA’s track record.
During a Senate investigation of abuses of the licensure practice in
1990, the Boston Globe reported that AMA and PhRMA lobbyists came to
Capitol Hill to promise Sen. Ted Kennedy (D-MA) that the program was not
part of any effort to convince doctors to prescribe PhRMA drugs. This
promise to self-regulate was never kept. In 2001 the New York Times reported
that the AMA generated $20 million dollars a year from licensure sales
to drug companies in a complex scheme to market drugs like Baycol to
doctors. In 2006, that number climbed to $40 million, and in 2007 it was
reported to be $45 million.
So while the AMA projects an image of representing doctors ...it is actually financially tethered to the drug
industry. Unless there are major structural changes to the AMA and its
sources of revenue, it is difficult to view the group as an honest
broker in the reform dialogue.
And when the AMA isn't promoting drugs for pay, it has been acting like a union that tries to raise the incomes of doctors at the expense of the rest of society. It also has its good side, but that is usually all the public thinks about it.
No comments:
Post a Comment